Search contract descriptions, companies and agencies.
SAGENT PHARMACEUTICALS PROPOFOL AND ROCURONIUM
Total Committed
$9.26M
Product or Service Description
Chemical and Pharmaceutical Products Manufacturing Machinery
Total Potential Value
$9.26M
Contracting Agency
Effective Date
July 2, 2020
Funding Department
OFFICE OF ACQ&MGMT POLICY
Type
Firm fixed price
Solicitation Procedure
Only one source
Extent Competed
Not competed
Reason
Urgency (Far 6.302 2)
Recent Contract Actions 
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Vendor | Description | Signed | Reason for Change | Amount Committed |
|---|---|---|---|---|
| SAGENT PHARMACEUTICALS, INC. | SAGENT PHARMACEUTICALS PROPOFOL AND ROCURONIUM | Aug. 15, 2020 | Exercise An Option | $2,760,000 |
| SAGENT PHARMACEUTICALS, INC. | SAGENT PHARMACEUTICALS PROPOFOL AND ROCURONIUM | July 6, 2020 | $6,500,000 |
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.